article thumbnail

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

Health Populi

That’s a summary of the demand side of the trends on the health economy which serve up huge challenges for legacy health care stakeholders: hospitals and health systems, health plans, pharmaceutical and medical tech companies, and clinicians.

article thumbnail

Day 3 Notes from the 42nd Annual J.P. Morgan Healthcare Conference

Sheppard Health Law

These days, institutional costs and pharmaceutical costs are almost equal, according to the Advisory Board, and together far outweigh professional physician and other provider costs. The WellBe fully employed provider model also is well engineered to build retention.